GLP-1 receptor agonists (semaglutide, liraglutide) are licensed in the UK for type 2 diabetes and weight management, not lymphoedema
The identification criteria and protocol for selection of TTR V30M patients, TTR V30M carriers, and healthy controls are provided in Supplemental Information under the heading cohort selection criteria
Market Segmentation Drug Type Insights (Revenue, USD BN, 2021 - 2033) Exenatide Liraglutide Sitagliptin Saxagliptin Alogliptin Others Disease Indication Insights (Revenue, USD BN, 2021 - 2033) Type 2 Diabetes Mellitus (T2DM) Weight Management Others Distribution Channel Insights (Revenue, USD BN, 2021 - 2033) Online Pharmacies Retail Pharmacies Hospital Pharmacies Regional Insights (Revenue, USD BN, 2021 - 2033) North America U.S
The stream velocity upon hitting dry powder causes similar shearing effects to shaking